Updated: January 28, 2026
How to Help Your Patients Save Money on NovoLog Mix 70/30: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- 2026 Pricing Context: What Changed
- Program 1: Novo Nordisk Copay Savings Card (Commercially Insured)
- Program 2: My Insulin Rx (No Insurance Required)
- Program 3: Novo Nordisk Patient Assistance Program (PAP)
- Program 4: Medicare Part D — $35/Month Insulin Cap
- Program 5: GoodRx Coupons (No Insurance or Under/Uninsured)
- Creating a Savings Workflow in Your Practice
A provider's guide to every NovoLog Mix 70/30 savings program in 2026: savings cards, patient assistance, Medicare caps, and how to connect patients to each program.
The cost of insulin has historically been a barrier to adherence — and non-adherence leads to avoidable complications and hospitalizations. With Novo Nordisk's significant pricing changes effective January 1, 2026, and a range of savings programs covering nearly every insurance situation, there are now more tools than ever to help your patients afford NovoLog Mix 70/30. This guide consolidates every available program with eligibility criteria and enrollment information you can share directly with your care team.
2026 Pricing Context: What Changed
Novo Nordisk reduced list prices on NovoLog Mix 70/30 by up to 75% effective January 1, 2026. The updated list prices are:
- NovoLog Mix 70/30 vial: approximately $72.34 per vial
- NovoLog Mix 70/30 FlexPen: approximately $139.71 per 5-pack
These price reductions benefit uninsured patients most directly. Patients with insurance may still pay different amounts depending on their plan's tier placement and benefit structure, making savings programs relevant for a wide range of coverage situations.
Program 1: Novo Nordisk Copay Savings Card (Commercially Insured)
Eligibility: Patients with commercial (employer-based or private) insurance. Not eligible for patients on Medicare, Medicaid, or other federal healthcare programs.
Benefit: Pay as little as $35 per 30-day supply (max savings $65 per fill). Pay no more than $99 for up to 35 mL (3 vials or 2 packs of pens) for up to 24 months.
How to enroll: novocare.com/diabetes/products/novologmix70-30/savings-offer.html or call 1-833-992-3299. Patient registers online and downloads the card. Present at pharmacy.
Clinical tip: Print QR codes to this enrollment page and include them in your after-visit summary printout for commercially insured patients starting or continuing NovoLog Mix 70/30.
Program 2: My Insulin Rx (No Insurance Required)
Eligibility: Open to all patients — no insurance required. Re-enrollment required each calendar year.
Benefit: $35 for a monthly supply of any combination of Novo Nordisk insulin products, up to 3 vials or 2 packs of pens (up to 35 mL). Available monthly.
How to enroll: novocare.com/diabetes/help-with-costs/help-with-insulin-costs/myinsulinrx.html or call 1-888-910-0632. Registration is online. Patient downloads card and presents at pharmacy.
Clinical tip: This is the right program for recently uninsured patients, patients in the insurance gap, or those between plans. Your social worker or care coordinator can often assist with enrollment.
Program 3: Novo Nordisk Patient Assistance Program (PAP)
Eligibility: Uninsured patients with limited income. Typically requires household income below 400% federal poverty level. Requires valid prescription and proof of income (pay stubs, tax return, or documentation of income loss).
Benefit: NovoLog Mix 70/30 at no cost.
How to apply: novocare.com/psp/PAP.html or call 1-866-310-7549. Applications can be completed online or with assistance from your office. Your staff can submit on behalf of patients in many cases.
Clinical tip: Consider flagging PAP-eligible patients in your EHR and assigning enrollment to a social worker or patient navigator at the time of prescription. Medication adherence improves dramatically when cost barriers are removed.
Program 4: Medicare Part D — $35/Month Insulin Cap
Eligibility: Medicare Part D enrollees whose plan covers NovoLog Mix 70/30. Under the Inflation Reduction Act, Part D plans must cap insulin cost-sharing at $35/month for covered insulins.
Benefit: No more than $35 per month for covered insulins, regardless of plan tier. The $2,000 annual out-of-pocket cap on all medications also applies starting in 2025.
Clinical tip: Confirm that your Medicare patients' Part D plan actually covers NovoLog Mix 70/30 on formulary — coverage is not universal. For patients whose plan doesn't cover it, GoodRx may offer a lower price (note: GoodRx cannot be combined with Medicare benefits).
Program 5: GoodRx Coupons (No Insurance or Under/Uninsured)
GoodRx coupons can reduce NovoLog Mix 70/30 to as low as $70-$73 per vial at participating pharmacies. GoodRx is especially useful for:
- Patients who are uninsured and don't qualify for PAP
- Patients whose insurance plan requires high deductibles or doesn't cover NovoLog Mix 70/30
- Patients comparing GoodRx vs. insurance copay to find the lower price
Creating a Savings Workflow in Your Practice
Consider implementing a standardized savings assessment at every visit for patients on NovoLog Mix 70/30:
- Ask at every visit: "Are you having any difficulty affording or finding your NovoLog Mix 70/30?"
- Document insurance status and flag uninsured/underinsured patients for My Insulin Rx or PAP enrollment.
- Provide the Novo Nordisk NovoCare phone number (1-844-668-6463) on after-visit summary for patients who need help navigating programs.
- If a patient is also having trouble finding NovoLog Mix 70/30 in stock, recommend medfinder.com to locate available pharmacies.
For more on helping patients locate NovoLog Mix 70/30 in stock, see our guide: How to Help Your Patients Find NovoLog Mix 70/30 in Stock. medfinder also supports provider offices — contact us to learn how to refer patients.
Frequently Asked Questions
For uninsured patients who qualify by income, the Novo Nordisk Patient Assistance Program provides NovoLog Mix 70/30 at no cost. For those who don't qualify for PAP, the My Insulin Rx program provides a monthly supply for $35 with no insurance required (up to 3 vials or 2 packs of pens). GoodRx coupons can also reduce cost to $70-$73 per vial. With Novo Nordisk's January 2026 price cuts, the list price itself is now approximately $72.34/vial.
Medicare Part D enrollees pay no more than $35 per month for covered insulins under the Inflation Reduction Act's insulin cap. Manufacturer copay cards are not available for Medicare patients. If NovoLog Mix 70/30 is not on a patient's Part D formulary, GoodRx may offer a lower cash price — but Medicare and GoodRx cannot be combined. Medicare patients with low incomes may also qualify for Extra Help (Low Income Subsidy), which further reduces medication costs.
Yes. Providers and their staff can help patients apply to the Novo Nordisk Patient Assistance Program at novocare.com/psp/PAP.html or by calling 1-866-310-7549. The application requires a valid prescription and proof of household income. Many practices assign PAP enrollment to a social worker, medical assistant, or patient navigator for efficiency. Prior authorization support from Novo Nordisk may also be available through NovoCare.
The Novo Nordisk NovoLog Mix 70/30 savings card is for commercially insured patients and allows them to pay as little as $35 per 30-day supply (max savings $65/fill). Patients enroll at novocare.com/diabetes/products/novologmix70-30/savings-offer.html or call 1-833-992-3299. You can also include this URL or a QR code in your after-visit summary printout for new or existing patients starting NovoLog Mix 70/30.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Ovide also looked for:
More about Ovide
30,515 have already found their meds with Medfinder.
Start your search today.





